Fig. 6
From: The prognosis biomarkers based on m6A-related lncRNAs for myeloid leukemia patients
The prognostic risk model was applied to clinical features of ML patients. A–D Kaplan-Meier curves of OS differences stratified by age, gender between the high- and low-risk groups in the training and testing set. E–H The risk score was compared between the low- and high-risk groups in the training and testing set. I The heatmap of the clinicopathological features (age, gender) and cluster. *p < 0.05 and ***p < 0.001